Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2006

Feb 2, 2006

29777_dirs_2006-02-01_ea507ee9-01ab-4aba-9011-5b818c53cfa4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-01-30

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-01-30 Common shares without par value M 23224 $41.9715 Acquired 216487 Direct
2006-01-30 Common shares without par value F 22867 $43.00 Disposed 193620 Direct
2006-01-30 Common shares without par value G 1398 Disposed 192222 Direct
2006-01-30 Common shares without par value G 466 Acquired 466 Indirect
2006-01-30 Common shares without par value G 466 Acquired 466 Indirect
2006-01-30 Common shares without par value G 466 Acquired 466 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-01-30 Option (right to buy) $41.9715 M 23224 Disposed 2006-02-08 common shares (23224) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 17895 Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2006.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.